Belfast’s GenoMe raises £300,000 for its ovarian cancer test
GenoMe team and investors. Image: GenoMe
The medtech start-up said its blood test for early detection of ovarian cancer could ‘potentially dramatically increase patient survival’.
GenoMe Diagnostics, a Belfast medtech start-up, has raised £300,000 in a seed round for its ovarian cancer diagnostics technology.
The start-up, a spin-out from Queen’s University Belfast that was founded last year, is developing a novel blood test for the earlier diagnosis of ovarian cancer.
The round of funding comes from QUBIS, a department of Queen’s University that is responsible for investing in university spin-outs and helping them commercialise, Deepbridge Capital, and Co-Fund NI, government-backed fund for investing in Northern Irish start-ups.